Ashley Gallagher, Editor

Study shows that shedding pounds potentially decreases the risk of diabetes, dyslipidemia, and high blood pressure.

The medication has met the criteria of overall survival for individuals with this type of liver cancer who were previously treated with sorafenib, Merck says.

Patients with senile dementia who have silent epileptic activity show improvement when taking this medication.

Study results presented at an American Heart Association conference show that 34% of individuals have high blood pressure.

Investigators at Stanford Medicine find that 72% of individuals who took the highest dose of ON-SXB were considered much or very much improved.

Treatment of round pneumonia should be followed up with a 2-view chest X-ray weeks later.

An intravenous immunoglobulin option along with glucocorticoids could be effective in fighting drug-induced erythroderma for patients with AIDS.

Study shows Lefamulin, omadacycline, ceftaroline, delafloxacin are beneficial in treating community-acquired pneumonia.

The overall response rate of ruxolitinib at week 24 was 49.7% compared with 25.6% for the best available therapy treatment for graft-versus-host-disease.

It demonstrated 93.2% efficacy 14 days afterward and greater than 90% for 4 or more months.

Survey results from Kantar show that people rate these factors more important than an active family life and financial security in terms of well-being.

In clinical trials, the majority of patients with atopic dermatitis treated with ruxolitinib had clear or almost clear skin.

These patients had comparable levels of antibodies to individuals without the disease after a 2-dose course of the vaccination.

Thomas Menighan, co-founder of PursueCare and the CEO Emeritus of the American Pharmacists Association, discusses a pharmacists role in National Recovery Month.

The results of 3 phase 3 trials showed that the drug offered greater proportions of individuals with the condition who met the endpoints of clinical remission and endoscopic response.

Phase 3 trial results show that the drug reduced the risk of death or reoccurrence by 35% for individuals with high-risk disease compared with the placebo.

Nearly 94.1% of individuals treated with the drug in the DESTINY-Breast03 study were still alive at the 1-year mark, according to a statement from AstraZeneca.

Stanford research results show that of nearly 39,000 individuals, just 22 had potential allergic reactions, and all recovered.

Surgical procedures and weight-loss drugs combat high hypertension in individuals who are obese or overweight, according to the American Heart Association.

In a phase 3 trial, the medication significantly reduced the risk of disease progression compared with individuals in a placebo group.

There are 4 essential epidermal growth factor receptor-mutant non-small cell lung cancer subgroups, according to new research results.

Study results showed that an individual with the blood disorder did not respond to treatment, including intravenous immunoglobulin, following their second dose of the Pfizer vaccination.

The results of a review by Murdoch Children’s Research Institute finds that pediatric patients who are vaccinated get protection from the long-term effects of the disease.

Investigators at the IMT School for Advanced Studies say that future rollouts should focus on workers, which would help avoid another lockdown.

Recent study results show that vitamin D may offer protection against critical disease and death.

The National Institutes of Health’s studies aim to research the long-term effects of the coronavirus.

The FDA approved Exkivity to treat non-small cell lung cancer along with Thermo Fisher Scientific’s Oncomine DX Target Test, which is intended to be a companion diagnostic for the treatment.

Investigators said that NanoSTING, can be shipped and stored without the need for freezing for up to 11 months.

Jason Ausili, PharmD, the Chief Clinical Officer of FDS Amplicare, discusses the impact on community pharmacies and patients of the recent announcement by the HHS regarding the amendment to the COVID-19 PREP Act.

Individuals in a study who received the food with BB-12 probiotic retained beneficial metabolites produced by the microbiota.